Hindmilk and weight gain in preterm very low-birthweight infants

Amali-Adekwu Ogechi1, Ogala William, Bode-Thomas Fidelia

  • 1Department of Paediatrics, Jos University Teaching Hospital, University of Jos, Jos, Nigeria.

Insights

Selective hindmilk feeding significantly improves weight gain in preterm very low-birthweight infants. This specialized feeding approach, utilizing the lipid-rich hindmilk, is recommended to enhance growth and potentially shorten hospital stays for these vulnerable infants.

Area of Science:

  • Neonatal Nutrition
  • Pediatric Gastroenterology
  • Infant Growth and Development

Background:

  • Preterm very low-birthweight infants often experience suboptimal weight gain due to high energy needs and limited volume tolerance.
  • Exclusive breastfeeding is ideal, but achieving adequate growth can be challenging for these infants.

Purpose of the Study:

  • To investigate the impact of selective hindmilk feeding on the growth of preterm very low-birthweight infants.

Main Methods:

  • A randomized controlled trial was conducted with preterm very low-birthweight infants.
  • Infants were assigned to either hindmilk feeding or composite breast milk feeding for two weeks.
  • Growth parameters measured included weight, occipitofrontal head circumference, and length.

Main Results:

  • Infants fed hindmilk demonstrated significantly higher rates of weight gain compared to those on composite milk (P < 0.0001 for small-for-gestational-age; P < 0.01 for appropriate-for-gestational-age).
  • Hindmilk had a 1.6-fold higher lipid content than composite milk.
  • No significant differences were observed in length or head circumference increases between the groups.

Conclusions:

  • Hindmilk feeding leads to improved weight gain in preterm very low-birthweight infants.
  • Predominant use of hindmilk is recommended for hospitalized preterm very low-birthweight infants to optimize growth.
  • This strategy may contribute to reducing the duration of hospital stays.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...